dr. shaw on sequencing strategies in alk-positive nsclc
Published 5 years ago • 311 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:05
dr. liu on sequencing therapy in alk-positive nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
9:53
sequencing therapy in alk nsclc
-
1:58
dr. shaw on crizotinib in alk-positive lung cancer
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
1:00:52
drshaw
-
2:37
crown: lorlatinib in treatment-naïve patients with alk-positive advanced nsclc
-
1:09:29
alktalk1:10:20alice shaw
-
6:36
sequencing strategies for alk-targeted therapy
-
1:21
dr. shaw on crizotinib resistance in alk-positive lung cancer
-
2:32
dr. shaw discusses ldk378 and alectinib (af802) for alk-positive nsclc
-
46:36
dr. shaw: alk-positive lung cancer presentation
-
6:02
shaw patterns of resistance in alk positive nsclc
-
2:26
dr. shaw on alectinib as first-line therapy in lung cancer
-
6:27
alk inhibitor sequencing in nsclc
-
2:16
dr. shaw discusses efficacy of lorlatinib in alk nsclc
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
1:52
dr. shaw on crizotinib versus chemotherapy in alk-positive nsclc
-
1:38
dr. alice shaw describes ldk378 in alk-positive non-small cell lung cancer
-
1:35
dr. shaw on the phase iii results of the alex trial in nsclc